Smoking and socio-economic status may affect myasthenia gravis

European Journal of Neurology

Volumn 20, Issue 3, 2013, Pages 453-460

  Maniaol, A H ^a   Boldingh, M ^a   Brunborg, C ^a   Harbo, H F ^a,b   Tallaksen, C M E ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cross sectional study; Environmental factors; Myasthenia gravis; Population based; Smoking; Socio economic status

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NORWAY; PRIORITY JOURNAL; SMOKING HABIT; SOCIAL CLASS; SOCIAL STATUS; WORK DISABILITY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NORWAY; PREVALENCE; SMOKING; SOCIAL CLASS; YOUNG ADULT;

EID: 84873998445     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03843.x     Document Type: Article

References (24)

1. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971; 38: 497-537.
2. Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol 2010; 10: 46.
3. Giraud M, Vandiedonck C, Garchon HJ. Genetic factors in autoimmune myasthenia gravis. Ann N Y Acad Sci 2008; 1132: 180-192.
4. Vincent A. Aetiological factors in development of myasthenia gravis. Adv Neuroimmunol 1994; 4: 355-371.
5. Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA 2005; 294: 2879-2888.
6. Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 279-283.
7. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004; 3: 394-400.
8. Kallberg H, Padyukov L, Plenge RM, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007; 80: 867-875.
9. Simon KC, van der Mei IA, Munger KL, et al. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 2010; 74: 1365-1371.
10. Ng SC, Woodrow S, Patel N, Subhani J, Harbord M. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 725-736.
11. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
12. Maniaol AH, Brunborg C, Tallaksen CM. Development and validation of a self-administered questionnaire for myasthenia gravis patients. Neuroepidemiology 2010; 34: 253-261.
13. Erikson R, Goldthorpe JH, Goldthorpe JH. The Constant Flux: A Study of Class Mobility in Industrial Societies. Oxford: Clarendon Press, 1992.
14. Mackenbach JP, Kunst AE, Cavelaars AE, Groenhof F, Geurts JJ. Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health. Lancet 1997; 349: 1655-1659.
15. Krokstad S, Westin S. Health inequalities by socioeconomic status among men in the Nord-Trondelag Health Study, Norway. Scand J Public Health 2002; 30: 113-124.
16. Hagen K, Vatten L, Stovner LJ, Zwart JA, Krokstad S, Bovim G. Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia 2002; 22: 672-679.
17. Hagen K, Zwart JA, Svebak S, Bovim G, Jacob SL. Low socioeconomic status is associated with chronic musculoskeletal complaints among 46, 901 adults in Norway. Scand J Public Health 2005; 33: 268-275.
18. Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia gravis in individuals over 40. Ann N Y Acad Sci 2003; 998: 424-431.
19. Heldal AT, Owe JF, Gilhus NE, Romi F. Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology 2009; 73: 150-151.
20. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004; 50: 849-857.
21. DiFranza JR, Savageau JA, Fletcher K, et al. Susceptibility to nicotine dependence: the Development and Assessment of Nicotine Dependence in Youth 2 study. Pediatrics 2007; 120: e974-e983.
22. Cokkinides V, Bandi P, McMahon C, Jemal A, Glynn T, Ward E. Tobacco control in the United States - recent progress and opportunities. CA Cancer J Clin 2009; 59: 352-365.
23. Kaukiainen L, Pirskanen R, Hokkanen E. Social aspects in myasthenia gravis. Acta Neurol Scand 1977; 55: 377-384.
24. Somnier FE. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 2005; 65: 928-930.